These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 16396838)

  • 21. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
    Sentürk S; Oğuz KK; Cila A
    Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-treatment changes of tumour perfusion parameters can help to predict survival in patients with high-grade astrocytoma.
    Sanz-Requena R; Revert-Ventura AJ; García-Martí G; Salamé-Gamarra F; Pérez-Girbés A; Mollá-Olmos E; Martí-Bonmatí L
    Eur Radiol; 2017 Aug; 27(8):3392-3400. PubMed ID: 27999986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps.
    Emblem KE; Nedregaard B; Nome T; Due-Tonnessen P; Hald JK; Scheie D; Borota OC; Cvancarova M; Bjornerud A
    Radiology; 2008 Jun; 247(3):808-17. PubMed ID: 18487536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome of surgically treated low-grade gliomas: a retrospective analysis of a single institute.
    Turkoglu E; Gurer B; Sanli AM; Dolgun H; Gurses L; Oral NA; Donmez T; Sekerci Z
    Clin Neurol Neurosurg; 2013 Dec; 115(12):2508-13. PubMed ID: 24225484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early prognostic factors related to progression and malignant transformation of low-grade gliomas.
    Jung TY; Jung S; Moon JH; Kim IY; Moon KS; Jang WY
    Clin Neurol Neurosurg; 2011 Nov; 113(9):752-7. PubMed ID: 21889256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors.
    Siegal T; Rubinstein R; Tzuk-Shina T; Gomori JM
    J Neurosurg; 1997 Jan; 86(1):22-7. PubMed ID: 8988077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas.
    Chaichana KL; McGirt MJ; Laterra J; Olivi A; Quiñones-Hinojosa A
    J Neurosurg; 2010 Jan; 112(1):10-7. PubMed ID: 19361270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
    Ellingson BM; Zaw T; Cloughesy TF; Naeini KM; Lalezari S; Mong S; Lai A; Nghiemphu PL; Pope WB
    J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High- and low-grade glioma differentiation: the role of percentage signal recovery evaluation in MR dynamic susceptibility contrast imaging.
    Aprile I; Giovannelli G; Fiaschini P; Muti M; Kouleridou A; Caputo N
    Radiol Med; 2015 Oct; 120(10):967-74. PubMed ID: 25762408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posttreatment high-grade glioma: usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence.
    Kim HS; Kim JH; Kim SH; Cho KG; Kim SY
    Radiology; 2010 Sep; 256(3):906-15. PubMed ID: 20634429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.
    Hakyemez B; Erdogan C; Bolca N; Yildirim N; Gokalp G; Parlak M
    J Magn Reson Imaging; 2006 Oct; 24(4):817-24. PubMed ID: 16958061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.
    Smith JS; Chang EF; Lamborn KR; Chang SM; Prados MD; Cha S; Tihan T; Vandenberg S; McDermott MW; Berger MS
    J Clin Oncol; 2008 Mar; 26(8):1338-45. PubMed ID: 18323558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
    Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ
    NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-grade gliomas in children: tumor volume response to radiation.
    Fisher BJ; Bauman GS; Leighton CE; Stitt L; Cairncross JG; Macdonald DR
    J Neurosurg; 1998 Jun; 88(6):969-74. PubMed ID: 9609290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility.
    Aronen HJ; Glass J; Pardo FS; Belliveau JW; Gruber ML; Buchbinder BR; Gazit IE; Linggood RM; Fischman AJ; Rosen BR
    Acta Radiol; 1995 Sep; 36(5):520-8. PubMed ID: 7640098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment monitoring in gliomas: comparison of dynamic susceptibility-weighted contrast-enhanced and spectroscopic MRI techniques for identifying treatment failure.
    Vöglein J; Tüttenberg J; Weimer M; Gerigk L; Kauczor HU; Essig M; Weber MA
    Invest Radiol; 2011 Jun; 46(6):390-400. PubMed ID: 21285888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partially resected gliomas: diagnostic performance of fluid-attenuated inversion recovery MR imaging for detection of progression.
    Winterstein M; Münter MW; Burkholder I; Essig M; Kauczor HU; Weber MA
    Radiology; 2010 Mar; 254(3):907-16. PubMed ID: 20177101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction.
    Gasparetto EL; Pawlak MA; Patel SH; Huse J; Woo JH; Krejza J; Rosenfeld MR; O'Rourke DM; Lustig R; Melhem ER; Wolf RL
    Radiology; 2009 Mar; 250(3):887-96. PubMed ID: 19244052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.